Meisner Lara's Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Jun 6, 2023
- Accession no.
- 0000899243-23-014615
- Filed
- Jun 6, 2023
- Trade date
- Jun 2-6, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $186.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meisner LaraCIK 0001883986 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | Common Stock | MOption exerciseAcquired | +1,875 | $14.00 | +$26,250 | 31,846 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −1,875 | $24.21 | −$45,393.75 | 29,971 | Direct | |
| Jun 5, 2023 | Common Stock | MOption exerciseAcquired | +499 | $18.51 | +$9,236.49 | 30,470 | Direct | |
| Jun 5, 2023 | Common Stock | SSaleDisposed | −499 | $25.03 | −$12,489.97 | 29,971 | Direct | |
| Jun 6, 2023 | Common Stock | MOption exerciseAcquired | +5,126 | $18.51 | +$94,882.26 | 35,097 | Direct | |
| Jun 6, 2023 | Common Stock | SSaleDisposed | −5,126 | $25.02 | −$128,252.52 | 29,971 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | Common Stock | MOption exerciseDisposed | −1,875 | $0.00 | $0 | 18,128 | Direct | |
| Jun 5, 2023 | Common Stock | MOption exerciseDisposed | −499 | $0.00 | $0 | 89,501 | Direct | |
| Jun 6, 2023 | Common Stock | MOption exerciseDisposed | −5,126 | $0.00 | $0 | 84,375 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.